A cost-effectiveness analysis of preimplantation genetic testing for aneuploidy (PGT-A) for up to three complete assisted reproductive technology cycles in women of advanced maternal age

被引:23
|
作者
Lee, Evelyn [1 ]
Costello, Michael F. [2 ]
Botha, Willings C. [3 ]
Illingworth, Peter [4 ]
Chambers, Georgina M. [5 ]
机构
[1] Univ New South Wales, Ctr Social Res Hlth, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
[3] Univ New South Wales, Ctr Big Data Res Hlth, Natl Perinatal Epidemiol & Stat, Sydney, NSW, Australia
[4] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
[5] IVF Australia Pty Ltd, Sydney, NSW, Australia
关键词
aneuploidy; assisted reproductive technology; cost-effectiveness analysis; cumulative live-birth rate; preimplantation genetic diagnosis;
D O I
10.1111/ajo.12988
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Current evidence suggests that preimplantation genetic testing for aneuploidy (PGT-A) used during assisted reproductive technology improves per-cycle live-birth rates but cumulative live-birth rate (CLBR) was similar to a strategy of morphological assessment (MA) of embryos. No study has assessed the cost-effectiveness of repeated cycles with PGT-A using longitudinal patient-level data. Aim To assess the cost-effectiveness of repeated cycles with PGT-A compared to MA of embryos in older women. Materials and Methods Micro-costing methods were used to value direct resource consumption of 2093 assisted reproductive technology-naive women aged >= 37 years undergoing up to three 'complete assisted reproductive technology cycles' (fresh plus cryopreserved embryos) with either PGT-A or MA in an Australian clinic between 2011 and 2014. Incremental cost-effective ratios were calculated from healthcare and patient perspectives with uncertainty assessed using non-parametric bootstrap methods. Cost-effectiveness acceptability curves were constructed to evaluate the probability of PGT-A being cost-effective over a range of willingness-to-pay thresholds. Results The CLBR and mean healthcare costs per patient were 30.90% and $22 962 for the PGT-A group, and 26.77% and $21 801 for the MA group, yielding an incremental cost-effective ratio of $28 103 for an additional live birth with PGT-A. At a willingness-to-pay threshold of $50 000 and above, there is more than an 80% probability of PGT-A being cost-effective from the healthcare perspective and a 50% likelihood from a patient perspective. Conclusion This is the first study to use real-world patient-level data to assess the cost-effectiveness of PGT-A in older women from the healthcare and patient perspectives. The findings contribute to the ongoing debate on the role of PGT-A in clinical practice.
引用
收藏
页码:573 / 579
页数:7
相关论文
共 44 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) IN GOOD PROGNOSIS PATIENTS
    Dunn, Ariel J.
    Flannagan, Kerry S. J.
    Hunkler, Kiley
    Hill, Micah J.
    Romanski, Phillip A.
    Torrealday, Saioa
    Diribe, Chinormso
    Lewis, Terrence D.
    DeCherney, Alan
    Devine, Kathleen
    Levy, Michael
    Combs, Joshua C.
    FERTILITY AND STERILITY, 2024, 122 (04) : E5 - E6
  • [2] THE COST-EFFECTIVENESS OF PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A): AN ANALYSIS OF 153,865 SART CYCLES.
    Lee, Malinda S.
    Lofgren, Katherine T.
    Thomas, Ann M.
    Lanes, Andrea
    Goldman, Randi H.
    Ginsburg, Elizabeth S.
    Hornstein, Mark D.
    FERTILITY AND STERILITY, 2019, 112 (03) : E234 - E234
  • [3] Economic analysis of preimplantation genetic testing for aneuploidy (PGT-A) by polar body biopsy in advanced maternal age
    Neumann, K.
    Sermon, K.
    Bossuyt, P.
    Goossens, V.
    Geraedt, J.
    Traeger-Synodinos, J.
    Parriego, M.
    Schmutzler, A.
    Van der Ven, K.
    Griesinger, G.
    HUMAN REPRODUCTION, 2019, 34 : 465 - 465
  • [4] The price of a euploid embryo identified from preimplantation genetic testing for aneuploidy (PGT-A): A cost analysis
    Goldman, R.
    Racowsky, C.
    Fox, J.
    Munne, S.
    Ribustello, L.
    Ginsburg, E.
    HUMAN REPRODUCTION, 2017, 32 : 417 - 418
  • [5] Is there a necessity to process preimplantation genetic aneuploidy testing (PGT-A) of embryos in all patients undergoing Assisted Reproductive Technology (ART) programs?
    Shishimorova, M.
    Tevkin, S.
    Jussubaliyeva, T.
    HUMAN REPRODUCTION, 2022, 37 : I442 - I443
  • [6] BATCHING OF BLASTOCYSTS TOGETHER WITH PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) IS A HIGHLY SUCCESSFUL STRATEGY FOR ADVANCED MATERNAL AGE AND YOUNGER WOMEN WITH DIMINISHED OVARIAN RESERVE.
    Haham, Lilach Marom
    Dviri, Michal
    Kuperman, Adi
    Roumia, Anjila
    Madjunkova, Svetlana
    Librach, Clifford Lawrence
    FERTILITY AND STERILITY, 2020, 114 (03) : E432 - E432
  • [7] EFFECT OF FEDERAL AND STATE ABORTION LEGISLATION ON ASSISTED REPRODUCTIVE TECHNOLOGY TRENDS: INCREASED UTILIZATION OF PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) IN PATIENTS <35 YEARS OF AGE.
    Bernard, Abigail L.
    Friedlander, Hilary
    White, Erin
    Raburn, Douglas
    Neal, Shelby
    Acharya, Kelly S.
    FERTILITY AND STERILITY, 2024, 122 (01) : E16 - E16
  • [8] Factors affecting biochemical pregnancy loss (BPL) in preimplantation genetic testing for aneuploidy (PGT-A) cycles: machine learning-assisted identification
    Ortiz, Jose A.
    Lledo, B.
    Morales, R.
    Manez-Grau, A.
    Cascales, A.
    Rodriguez-Arnedo, A.
    Castillo, Juan C.
    Bernabeu, A.
    Bernabeu, R.
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2024, 22 (01)
  • [9] THE FIRST CUT IS NOT THE DEEPEST: PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) DOES NOT INCREASE MONOZYGOTIC TWINNING AND SIGNIFICANTLY DECREASES DIZYGOTIC TWINS WITH ASSISTED REPRODUCTIVE TECHNOLOGY (ART).
    Friedenthal, J.
    Maxwell, S. M.
    McCulloh, D. H.
    Grifo, J. A.
    FERTILITY AND STERILITY, 2018, 110 (04) : E71 - E71
  • [10] Pre-implantation genetic testing (PGT) is particularly more cost-effective in 41-42 yr-old women: A cost-effectiveness analysis of PGT in women with advanced maternal age
    Polat, M.
    Bozdag, G.
    Yarali, I.
    Mumusoglu, S.
    Sokmensuer, L. Karakoc
    Yarali, H.
    HUMAN REPRODUCTION, 2017, 32 : 412 - 412